-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603.P1.42 603. Lymphoid Oncogenesis: Basic: Poster I

Symposia: Lymphoid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, ALL, Fundamental Science, Apoptosis, Adult, Lymphomas, Non-Hodgkin lymphoma, Translational Research, CHIP, Genomics, Bioinformatics, Plasma Cell Disorders, B Cell lymphoma, Hematopoiesis, T Cell lymphoma, Diseases, Immune mechanism, Immunology, Aggressive lymphoma, Lymphoid Malignancies, Biological Processes, Technology and Procedures, Gene editing, Molecular biology, Study Population, Human, Pathogenesis, Animal model, Omics technologies
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Waseem Gul Lone, PhD1*, Alyssa Bouska, PhD1*, Tayla B Heavican-Foral, PhD2, Tyler A Herek, Ph.D1*, Ab Rauf Shah, Ph.D1*, Abdul Rouf Mir, PhD1*, Mahfuza Afroz Soma, MS1*, Dylan T. Jochum, BS1, Ruimeng Yang, PhD3*, Xuxiang Liu, PhD4*, Jeffrey Cannatella, M.D.1*, Catalina Amador, MD5*, Andrew L. Feldman, MD6, Wing Chung Chan, MD4 and Javeed Iqbal, PhD, MSc1*

1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
2Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Department of Pathology, City of Hope National Medical Center, Los Angeles, AL
4Department of Pathology, City of Hope National Medical Center, Duarte, CA
5University of Miami, Miami, FL
6Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Xuxiang Liu, PhD1*, Pin Yu Hou, MS2*, Krystie Chew3*, Ruimeng Yang, PhD3*, Anurag Kumar, PhD3*, Jaehyuk Choi, MD, PhD4, Javeed Iqbal, PhD, MSc5* and Wing Chung Chan, MD1

1Department of Pathology, City of Hope National Medical Center, Duarte, CA
2City of Hope National Medical Center, Duarte
3City of Hope National Medical Center, Duarte, CA
4Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL
5Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

Robert M Chavez1,2*, Doris R. Powell1*, Kiran Lakhani1*, John Attelah1*, Erin Flynt, PhD3*, Terry Connolly, PhD3*, Mark Hamilton, MD4, George Mulligan, PhD4, Daniel Auclair, PhD4*, Jonathan Keats, PhD5*, Paula M Vertino, PhD, BS6*, Lawrence H. Boise, PhD1, Sagar Lonial, MD7*, Karen N Conneely, PhD2* and Benjamin G. Barwick, PhD1

1Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA
2Department of Human Genetics, Emory University School of Medicine, Atlanta, GA
3K36 Therapeutics, Cambridge, MA
4Multiple Myeloma Research Foundation, Norwalk, CT
5Translational Genomics Research Institute, Phoenix, CA
6University of Rochester, Rochester, NY
7Winship Cancer Institute, Atlanta, GA

Anurag Kumar, PhD1*, Qi Wei, MD2*, Ruimeng Yang, PhD3*, Xuxiang Liu, PhD4*, Jibin Zhang, Ph.D.5*, Alyssa Bouska, PhD6*, Javeed Iqbal, PhD, MSc6* and Wing Chung Chan, MD4

1Anatomy Pathology, National Medical Centre City of Hope, Duarte, CA
2Guangzhou Dadao North Street NO. 1838, Guangzhou, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangzhou, China
3City of Hope National Medical Center, Duarte, CA
4Department of Pathology, City of Hope National Medical Center, Duarte, CA
5National Medical Centre City of Hope, Duarte, CA
6Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

Linda Resar, MD1, Jung-Hyun Kim, PhD2*, Li Z Luo, PhD3*, Katharina Hayer4*, Camilo Arenas Merizalde, BS5*, Leslie Cope, PhD6*, Andrei Thomas-Tikhonenko, PhD7,8 and Sarah K Tasian, MD9

1Division of Hematology, Departments of Medicine, Oncology & Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD
2The Johns Hopkins University School of Medicine, Baltimore, MD
3Department of Medicine, Division of Hematology, The Johns Hopkins University School of Medicine, Baltimore, MD
4Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
5Children's Hospital of Philadelphia, Philadelphia
6Johns Hopkins University School of Medicine, Baltimore, MD
7Division of Cancer Pathobiology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
8Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
9Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA

Ruimeng Yang, PhD1*, Xuxiang Liu, PhD2*, Jibin Zhang, Ph.D.3*, Abdul Rouf Mir, PhD4*, Waseem Gul Lone, PhD4*, Yuping Li, PhD5*, Krystie Chew3*, Claire Wu6*, Jasmine Zain, MD7, Joo Y Song, MD2*, Javeed Iqbal, PhD, MSc4* and Wing Chung Chan, MD2

1Department of Pathology, City of Hope National Medical Center, Los Angeles, AL
2Department of Pathology, City of Hope National Medical Center, Duarte, CA
3City of Hope National Medical Center, Duarte, CA
4Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
5Anatomy Pathology, National Medical Centre City of Hope, Duarte, CA
6City of Hope, Los Angeles, China
7City of Hope, Duarte, CA

Mrinal Joshirao, MD1,2, Inge Van Der Werf2*, Jessica Pham, BS2*, Antonio W Ruiz, BS2*, Neha Katragadda, BS2*, Emma E Klacking, BS2*, Elsa Molina, PhD3*, Ludmil Alexandrov, PhD4*, Thomas Whisenant, PhD5* and Catriona Jamieson, MD, PhD6

1Rady Children's Hospital, University of California San Diego, San Diego, CA
2Division of Regenerative Medicine, Department of Medicine, and Sanford Stem Cell Institute, UCSD, La Jolla, CA
3Next Generation Sequencing & Genomics Core, Salk Institute for Biological Studies, La Jolla, CA
4Bioengineering, Center for Molecular Medicine, and Sanford Stem Cell Institute, UCSD, La Jolla, CA
5Center for Computational Biology and Bioinformatics, UCSD, La Jolla, CA
6Sanford Stem Cell Institute, CIRM UC San Diego Alpha Stem Cell Clinic, La Jolla, CA

Soo Yeon Hwang, PhD, PharmD1*, Helgi Nikoli2*, Selina Chen-Kiang, PhD3, Caitlin Gribbin, MD4*, Peter Martin, MD4 and Jihye Paik, PhD5

1Pathology, Weill Cornell Medicine, New york, NY
2Weill Cornell Medicine, New york, NY
3Weill Cornell Medicine, New York, NY
4Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
5Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY

Marina E Michaud1, Jodi Dougan2*, Dailia B. Francis, MD, PhD3, Mojtaba Bakhtiari, MD1*, Christopher C. Porter, MD4* and Manoj Bhasin, PhD1

1Department of Pediatrics, Emory University, Atlanta, GA
2Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
3Department of Pediatrics, Emory University School of Medicine, Brookhaven, GA
4Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA

Areya Tabatabai1*, Sebastian Klein1*, Svenja Höfmann2*, Tanja Zhou1*, Felix Theiss3*, Ruth Flümann, MD4*, Michael Möllmann1*, Maximilian Hartnack3*, Stefanie Kesper3*, Aastha Arora1*, Gero Knittel, PhD1* and Hans Christian Reinhardt, MD5

1Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, NRW, Germany
2Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
3Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
4Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, NRW, Germany
5Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Deborah Piffaretti, PhD1*, Martin Richard Faderl, PhD1*, Federico Jauk, MD1*, Adalgisa Condoluci, MD1,2, Lodovico Terzi Di Bergamo1*, Gabriela Forestieri1*, Ricardo Koch, PhD1*, Katia Pini1*, Joyce Marques de Almeida, MD1*, Ilaria Romano, MD1,2, Matin Salehi1*, Alessio Bruscaggin, PhD1*, Simone Bocchetta, PhD1*, Georgia Alice Galimberti1*, Maria Cristina Pirosa, MD1,2, Alexandar Tzankov, MD, PhD3*, Emanuele Zucca, MD4,5 and Davide Rossi, MD, PhD1,2,4

1Institute of Oncology Research, Laboratory of Experimental Hematology, Bellinzona, Switzerland
2Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
3Medical Genetics and Pathology, University of Basel, Basel, Switzerland
4Università della Svizzera italiana, Faculty of Biomedical Science, Lugano, Switzerland
5Division of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland

Hiroyuki Murakami1*, Ryota Chijimatsu, PhD2*, Hideki Ujiie3*, Yusuke Naoi, MD1*, Kazutaka Sunami, MD, PhD4, Kazuhiko Yamamoto, MD, PhD5*, Soichiro Fujii, MD, PhD6*, Tomofumi Yano, MD, PhD7*, Keisuke Seike, MD, PhD8*, Hideaki Fujiwara, MD, PhD8, Noboru Asada, MD, PhD8, Nobuharu Fujii, MD, PhD9*, Ken-ichi Matsuoka, MD, PhD8*, Tomohiro Urata, MD1*, Kazuhiro Ikeuchi, MD1*, Hiroki Kobayashi, MD10*, Yasuharu Sato, PhD11*, Shuta Tomida, PhD12*, Yoshinobu Maeda, MD, PhD1 and Daisuke Ennishi, MD, PhD13

1Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
2Center of Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan
3Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan
4Department of Hematology, NHO, Okayama Medical Center, Okayama, Japan
5Department of Hematology and Oncology, Okayama City Hospital, Okayama, Japan
6Department of Hematology, Japanese Red Cross Okayama Hospital, Okayama, Japan
7Department of Internal Medicine, Okayama Rosai Hospital, Okayama, Japan
8Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
9Division of Blood Transfusion, Okayama University Hospital, Okayama, Japan
10Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, OKA, Japan
11Department of Molecular Hematopathology, Okayama University, Okayama, Japan
12Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sci, Okayama, JPN
13Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan

Meagan Vacek, DO1, Jacqelyn Nemechek, PhD2*, Irina Pushel, PhD3*, Bradley Thornton4*, Molly Leyda2*, Priyanka Prem Kumar4*, Midhat S Farooqi, MD, PhD3,5,6*, Erin M. Guest, MD7, Jay Vivian, PhD4,5,8* and John M. Perry, PhD2,5,8

1Division of Hematology/Oncology/Bone Marrow Transplant, Children's Mercy Hospital, Kansas City, MO
2Division of Hematology/Oncology/Bone Marrow Transplant, Children's Mercy Kansas City, Kansas City, MO
3Genomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO
4Division of Clinical Genetics, Children's Mercy Kansas City, Kansas City, MO
5University of Missouri - Kansas City, Kansas City, MO
6Department of Pathology, University of Kansas Medical Center, Kansas City, KS
7Hematology/Oncology/BMT, Children's Mercy Kansas City, Kansas City, MO
8University of Kansas Medical Center, Kansas City, KS

Makoto Iwasaki, MD, PhD1, Caroline MacVicar, BA2*, Anna B Rider, BSc3*, Aliyah R. Sohani, MD4*, Valentina Nardi, MD5*, Josie G Ford, BSc6, Kusha Chopra, BA2*, Jeffrey A. Barnes, MD, PhD7 and Salvia Jain, MD4

1Massachusetts General Hospital Cancer Center, Boston, MA
2Department of Medicine, Massachusetts General Hospital, Boston, MA
3Department of Pathology, Massachusetts General Hospital, Boston, MA
4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA
5Pathology Division, Harvard Medical School, Boston, MA
6Department of Medicine, Massachusetts General Hospital, Farmington, CT
7Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA

Amna De Bolòs, MS1,2*, Maria Carreras-Caballé1*, Marta Sureda-Gómez1*, Marta Leonor Rodríguez1*, Stella Charalampopoulou1*, Robert Albero1*, Alba Maiques-Diaz1*, Heribert Playà-Albinyana2,3,4*, Dolors Colomer1,2,3,5*, José Ignacio Martín-Subero1,5,6*, Elías Campo1,2,3,5,6, David Reverter6,7*, Josep Villanueva2,8* and Virginia Amador1,2*

1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain
3Universitat de Barcelona (UB), Barcelona, Spain
4Institut D'Investigacions BiomèDiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
5Hematopathology Section, Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain
6Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
7Institut de Biotecnologia i de Biomedicina (IBB) and Dept. de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain
8Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

*signifies non-member of ASH